What is Tympanogen?
Tympanogen, Inc. is a specialized medical technology firm focused on the development of innovative ear, nose, and throat devices. The company's core value proposition centers on its proprietary gel technology, which is designed to replace complex, invasive surgical procedures with streamlined, office-based alternatives. Its flagship product, Perf-Fix, represents a significant advancement in tympanoplasty, allowing for the regeneration of the tympanic membrane in a 10-minute office visit. By eliminating the need for general anesthesia and extensive surgical preparation, Tympanogen is effectively lowering the barrier to care while maintaining high clinical success rates. This approach positions the company as a high-growth player in the medical device sector, targeting a substantial market segment currently underserved by traditional surgical methods.
How much funding has Tympanogen raised?
Tympanogen has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2022): $1M with participation from NO/LA Angel Network
Key Investors in Tympanogen
NO/LA Angel Network
A prominent investment network focused on providing financial backing and mentorship to emerging companies, emphasizing strategic guidance and business development.
What's next for Tympanogen?
With the recent capital injection, Tympanogen is poised to scale its operational capabilities and expand its clinical footprint. The strategic focus will likely shift toward regulatory milestones and the commercial rollout of the Perf-Fix platform. As the company moves into this next phase of growth, the emphasis will remain on demonstrating the long-term efficacy of its gel-based regeneration technology to healthcare providers and hospital systems. By leveraging this financial backing, the firm aims to solidify its market position as a leader in office-based ENT solutions, potentially setting a new standard for tympanic membrane repair and reducing the overall economic burden on the healthcare system.
See full Tympanogen company page
